Clinical Trial

Alpha and Omega of Lifestyle Therapy

Study acronym: Alpha&Omega
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to investigate the effects of double-blinded, randomized placebo-controlled n3-fatty acid supplementation (1000 mg day-1) and 13 weeks of resistance training on muscle function/biology and systemic health in individuals with obesity (BMI\>30) and lean individuals (BMI\<30)
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-02-19; most recent amendment 2022-08-08.
Trial Details
NCT Number NCT04279951
Lead Sponsor Inland Norway University of Applied Sciences
Conditions Obesity
Enrollment 150 participants
Start Date 2019-09-02
Primary Completion 2022-03-30 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2022-08-09